Development of induced pluripotent stem (iPS) cells from patients with muscular disorders for the study of the pathogenesis of the diseases and development of therapies

Development of induced pluripotent stem (iPS) cells from patients with muscular disorders for the study of the pathogenesis of the diseases and development of therapies - iPS cell studies of muscular disorders

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000008958

Enrollment

Registered

2012-09-23

Start date

2011-09-12

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skeletal muscle disease Myotonic dystrophy Muscular dystrophies

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Either of the following subjects suffering from muscular disorders: 1) Subjects scheduled to undergo surgery or biopsy for medical reasons. 2) Subjects from which cultured cells was harvested with previous biopsy and gave consent for the research use of the biopsied samples.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

Measure	Time frame
Phenotypes of cell lines derived from muscular disorders	—

Countries

Japan

Contacts

Public ContactMasanori P. Takahashi

Osaka University Graduate School of Medicine Department of Neurology

mtakahas@neurol.med.osaka-u.ac.jp06-6879-3571

Outcome results